Literature DB >> 17171404

New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions.

Yosuke Okamura1, Makoto Handa, Hidenori Suzuki, Yasuo Ikeda, Shinji Takeoka.   

Abstract

To construct platelet substitutes that have hemostatic properties over a wide range of shear rates, we used fibrinogen gamma-chain carboxy-terminal sequence HHLGGAKQAGDV (H12), which recognizes activated platelets at low shear rates, and a recombinant water-soluble moiety of the platelet glycoprotein (rGPIbalpha), which recognizes von Willebrand factor at high shear rates. Three kinds of samples were prepared for this purpose: H12-conjugated latex beads (H12-latex beads), rGPIbalpha-latex beads, and H12/rGPIbalpha-latex beads. These samples were evaluated in thrombocytopenia-imitation blood at various flow conditions. Based on ADP-induced platelet aggregation studies, the H12-latex beads significantly enhanced platelet aggregation via H12 binding with GPIIb/IIIa activated on the surface of activated platelets, whereas the rGPIbalpha-latex beads did not support platelet aggregation. In the case of the H12/rGPIbalpha-latex beads, the function of H12 was suppressed by steric hindrance from the larger rGPIbalpha bound to the latex bead. A mixture of the H12-latex beads and the rGPIbalpha-latex beads adhered to a collagen surface over a wide range of shear rates. In particular, at high shear rates, a cooperative effect was observed in the enhancement of platelet thrombus formation compared with H12-latex beads or rGPIbalpha-latex beads alone. We propose that a mixed system of H12- and rGPIbalpha-conjugated nanoparticles is a more effective platelet substitute than each of the beads used alone and has enhanced platelet aggregation properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171404     DOI: 10.1007/s10047-006-0345-0

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  31 in total

1.  Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion.

Authors:  T Kitaguchi; M Murata; K Iijima; K Kamide; T Imagawa; Y Ikeda
Journal:  Biochem Biophys Res Commun       Date:  1999-08-11       Impact factor: 3.575

Review 2.  Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation.

Authors:  Z M Ruggeri
Journal:  Best Pract Res Clin Haematol       Date:  2001-06       Impact factor: 3.020

3.  Functional self-association of von Willebrand factor during platelet adhesion under flow.

Authors:  Brian Savage; Jan J Sixma; Zaverio M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

4.  Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow.

Authors:  A Bonnefoy; Q Liu; C Legrand; M M Frojmovic
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

5.  Conjugation of von Willebrand factor-binding domain of platelet glycoprotein Ib alpha to size-controlled albumin microspheres.

Authors:  S Takeoka; Y Teramura; H Ohkawa; Y Ikeda; E Tsuchida
Journal:  Biomacromolecules       Date:  2000       Impact factor: 6.988

6.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor.

Authors:  C A Siedlecki; B J Lestini; K K Kottke-Marchant; S J Eppell; D L Wilson; R E Marchant
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

7.  Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets.

Authors:  S C Lam; E F Plow; M A Smith; A Andrieux; J J Ryckwaert; G Marguerie; M H Ginsberg
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

8.  Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex.

Authors:  S S Graham; N J Gonchoroff; J L Miller
Journal:  Am J Clin Pathol       Date:  2001-01       Impact factor: 2.493

9.  Rolling properties of rGPIbalpha-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditions.

Authors:  Shinji Takeoka; Yuji Teramura; Yosuke Okamura; Eishun Tsuchida; Makoto Handa; Yasuo Ikeda
Journal:  Biochem Biophys Res Commun       Date:  2002-08-23       Impact factor: 3.575

10.  Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding.

Authors:  M Murata; J Ware; Z M Ruggeri
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

View more
  8 in total

1.  Journal of Artificial Organs 2006: the year in review.

Authors:  Y Sawa; T Horiuchi; A Kishida; T Masuzawa; M Nishimura; E Tatsumi; Y Tomizawa; H Watanabe
Journal:  J Artif Organs       Date:  2007-06-20       Impact factor: 1.731

Review 2.  Biomechanics.

Authors:  Masahiro Nishida
Journal:  J Artif Organs       Date:  2009-03-29       Impact factor: 1.731

3.  A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets.

Authors:  Hassan Haji-Valizadeh; Christa L Modery-Pawlowski; Anirban Sen Gupta
Journal:  Nanoscale       Date:  2014-05-07       Impact factor: 7.790

Review 4.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

5.  Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jan Simak; Jennifer B Hall; Jana Semberova; Silvia H De Paoli Lacerda; Scott E McNeil
Journal:  Mol Pharm       Date:  2011-11-10       Impact factor: 4.939

Review 6.  Bioinspired artificial platelets: past, present and future.

Authors:  Norman F Luc; Nathan Rohner; Aditya Girish; Ujjal Didar Singh Sekhon; Matthew D Neal; Anirban Sen Gupta
Journal:  Platelets       Date:  2021-08-30       Impact factor: 3.862

Review 7.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

Review 8.  Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation.

Authors:  Shruti Raghunathan; Julie Rayes; Anirban Sen Gupta
Journal:  J Thromb Haemost       Date:  2022-04-26       Impact factor: 16.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.